Novavax Inc (NVAX)

$51.67 0.14 (0.27%)
16:00 EDT NVAX Stock Quote Delayed 30 Minutes

The Longer the Wait, The Smaller the Opportunity for Novavax

The delay in FDA approval is making the opportunity smaller for Novavax, but the opportunity still remains. NVAX stock is a hold.

Novavax: The Party’s Over

Will Novavax Stock Continue to Trend Lower?

Novavax Stock Up on Swiss Approval of Nuvaxovid

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 3.85B
PE Ratio -2.90
EPS -17.81
Volume (Avg. Vol.) 4.85M
Day's Range $48.51 - $52.04
52-Week Range $34.88 - $277.80
Dividend & Yield N/A (N/A)